Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296861) titled 'HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Developmen... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07298434) titled 'Study of VYD2311 for the Prevention of COVID-19' on Dec. 18, 2025. Study Type... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296328) titled 'Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in Peopl... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296744) titled 'Pivotal Randomized Study of the SUpira System in Patients Undergoing High-Risk... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296887) titled 'CARE Tool Study Aim 3' on Dec. 18, 2025. Study Type: Interventional Study D... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296991) titled 'VR Stimulation of Exercise Response in Sedentary Humans' on Dec. 18, 2025. St... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296133) titled 'GAMES Intervention in MCI (Mild Cognitive Impairment)' on Dec. 18, 2025. Stud... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296770) titled 'An Artificial Intelligence Driven Approach to Optimize Patient Selection for a... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296848) titled 'Health Communications for Adults Smoking Nondaily' on Dec. 18, 2025. Study Ty... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07299019) titled 'A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Scler... Read More